- $3.29bn
- $2.71bn
- $398.99m
- 72
- 17
- 92
- 63
Annual cashflow statement for Zai Lab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -269 | -704 | -443 | -335 | -257 |
| Depreciation | |||||
| Non-Cash Items | 29.9 | 124 | 133 | 86.8 | 98 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 18.3 | 24.5 | -65.8 | 40.6 | -67.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -216 | -549 | -368 | -198 | -215 |
| Capital Expenditures | -10.7 | -18.9 | -25 | -8.49 | -61.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -544 | 269 | 445 | -2.29 | -314 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -555 | 250 | 420 | -10.8 | -375 |
| Financing Cash Flow Items | — | -4.25 | -7.6 | -8.8 | -0.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,132 | 820 | -1.73 | -6.43 | 350 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 366 | 522 | 44.4 | -218 | -240 |